Skip to content

Apotheek Lox

Active
Public limited companyfounded 1992active for 33 yearsKoning Albertlaan 174, 3010 Leuven, BelgiumKBO/BCE: BE 0449.107.822
Summary

Apotheek Lox has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €3.7m and a net result of €205,355. Equity is growing by about 2.8% per year across the filed financial years. Its solvency ranks better than 81% of 9,538 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€5.3mtotal assets 2024
Staff
4.4 FTE
Equity
€3.7m
Profit
€205,355
Turnover not published (abbreviated format)
Financial health
56 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
Tigelox Comm.V.
Board
4 members
  • TiLoxManaging director · permanent representative Tim Lox
2025 accounts not filed, 85 days past the deadline2 of 5 deeds summarised
Why 56raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 14-08-2025)lowers riskFounded in 1992Size: 4.4 FTE, total assets €5.3mEquity €3.7m (69.5% of total assets)Show the evidence

Checked score

Score 2024
56 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 57% of its sector peers (NACE 47, micro)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2023
Strong
Solvency 95=
equity 69.5% of total assets
Liquidity 47-7
short-term debt 30.5% · cash 7.9%
Profitability 74+1
return on assets 3.9%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025lowest value 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.3%▲ +0.1 percentage points vs 09-2026highest value
Credit of up to €200,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity ample (current ratio 3.25, compared with 3.31 in 2023, above the usual 1.5; short-term debt: 30.5% and cash: 7.9% of total assets), and 30.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 80% on solvency, 47% on liquidity, 58% on profitability and 44% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2024 (filed 14-08-2025)
NBB · annual accounts
lowers risk · Founded in 1992
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: 4.4 FTE, total assets €5.3m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €3.7m (69.5% of total assets)
NBB · annual accounts
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 85 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline24-10-2026 today
raises risk · 2024 accounts filed 12 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 12-08-2025, 12 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
12 days late
2023
28 days late
2022
1 day late
2021
25 days late
2020
30 days late
2019
49 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 24 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Tigelox CommV. (director)Permanent representatives: Geert Lox and…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Positive: Among the best 5% on equitysector median €332,666 · 9,540 companies €3.7m View
  • Caution: 2025 accounts not fileddeadline was 31-07-2026 85 days past the deadline View
  • New directorslatest change 01-01-2026 · 4 in office 3 joined View
  • Controlled by Tigelox Comm.V. parent View
  • Positive: 7 profitable years in a rowprofit 2024: €205,355 7 years View

By topic

Financials

Financial year
2024
Total assets
€5.3m
Profit
€205,355
Solvency
69.5%
Total assets▲ 2.4%
Net result
20182024
Go to Financials

Board & ownership

Board
4 members
Parent
Tigelox Comm.V.
  • Begga WeymansDirector
  • Geert LoxDirector
  • TiLoxManaging director
  • TIGELOXDirector
Go to Board & ownership

Timeline

Events
36
Since
1993
  1. 31-12-2023Weakest financial year
  2. 12-12-2023Resignation: TIGELOX (director)
  3. 01-08-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
30-12-1992
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
34
Annual meeting
First Wednesday of June at 09:00
Purpose
“De magistrale bereiding van geneesmiddelen,farmaceutische…” (deed in Dutch)
Go to Articles of association

Key facts about Apotheek Lox

What is the company number of Apotheek Lox?
0449.107.822. In Belgium the VAT number is the company number with BE in front: BE 0449.107.822.
Where is Apotheek Lox based?
The registered office is at Koning Albertlaan 174, 3010 Leuven.Company details
What does Apotheek Lox do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Lox?
Public limited company (NV).
When was Apotheek Lox founded?
On 30-12-1992.
Is Apotheek Lox still active?
Yes, Apotheek Lox is an active enterprise in the KBO register.
How many employees does Apotheek Lox have?
On average 4.4 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of Apotheek Lox?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek Lox profitable?
In financial year 2024, Apotheek Lox made a profit of €205,355.
Where can I find the annual accounts of Apotheek Lox?
Apotheek Lox filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Companies related to Apotheek Lox

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.